Related Experiment Videos
Evaluating de novo sequencing in proteomics: already an accurate alternative to database-driven peptide
Thilo Muth1, Bernhard Y Renard1
1Research Group Bioinformatics, Robert Koch Institute, Berlin, Germany.
Briefings in Bioinformatics
|April 4, 2017
Summary
Computational de novo peptide sequencing shows moderate accuracy on experimental data but excels on simulated data. Novor demonstrated superior performance in accuracy and speed compared to PEAKS and PepNovo for mass spectrometry analysis.
Area of Science:
- Proteomics
- Computational Biology
- Mass Spectrometry
Background:
- Database search methods dominate mass spectrometry (MS)-based shotgun proteomics.
- High-resolution MS data enables improved computational de novo peptide sequencing.
- De novo sequencing bypasses the need for reference databases.
Purpose of the Study:
- To evaluate the performance of de novo sequencing algorithms on high-resolution MS data.
- To compare the accuracy and speed of Novor, PEAKS, and PepNovo.
- To identify common de novo sequencing errors and influencing factors.
Main Methods:
- Processed four experimental MS datasets from different instrument types and fragmentation modes (collision-induced dissociation and higher energy collisional dissociation).
- Evaluated Novor, PEAKS, and PepNovo software packages.
- Tested algorithm accuracy on simulated spectra generated from peak intensity prediction software.
Main Results:
- Novor exhibited the best performance in predicting full peptide, tag-based, and single-residue sequences.
- Novor achieved a 12-17x speedup compared to PEAKS.
- Algorithms showed moderate accuracy (approx. 35%) on experimental data but significantly higher accuracy (up to 84%) on simulated data.
Conclusions:
- Novor is the top-performing algorithm for de novo peptide sequencing in terms of accuracy and speed.
- De novo sequencing shows promise for broader application in proteomics, especially with advancements in data quality and algorithms.
- Understanding sequencing errors and data quality factors is crucial for improving de novo sequencing reliability.